Maria Majellaro

Chief Scientific Officer

Spain

Research Interests

Explore related searches

Professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Maria Majellaro is the Chief Scientific Officer at Celtarys Research SL in Spain. Her research focuses on the discovery and characterization of GPCR ligands, with recent articles exploring cannabinoid receptors and adenosine receptor antagonists in the context of cancer. She has contributed to advancements in pharmacology through innovative assay development and molecular modeling techniques.

Articles (10)

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (11)

Willem Jespers

Assistant Professor

Leiden University

NETHERLANDS

View details

Irene Reyes-Resina

Associate Professor

University of Barcelona

SPAIN

View details

Mónica Gómez Boado

SPAIN

View details

Eddy Sotelo

Catedrático de Universidad/ Full Professor

Universidade de Santiago de Compostela

SPAIN

View details

Jose Brea

Universidade de Santiago de Compostela

SPAIN

View details

Antón Leandro Martínez Rodríguez

SPAIN

View details

Hugo Gutiérrez de Terán

Associate professor

Uppsala University

SWEDEN

View details

Álvaro Gil

Associate Professor

Universidade de Santiago de Compostela

SPAIN

View details

Xinsong Chen

Karolinska University Hospital

SWEDEN

View details

Cosimo Altomare

University of Bari Aldo Moro

ITALY

View details

Apple Tay

Karolinska Institutet

SWEDEN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Maria Majellaro

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

A Robust and Efficient FRET-Based Assay for Cannabinoid Receptor Ligands Discovery

A<sub>2B</sub> adenosine receptor antagonists rescue lymphocyte activity in adenosine-producing patient-derived cancer models.

Exploring Non-orthosteric Interactions with a Series of Potent and Selective A<sub>3</sub> Antagonists.

Optimization of 2-Amino-4,6-diarylpyrimidine-5-carbonitriles as Potent and Selective A<sub>1</sub> Antagonists.

Identification of A2BAR as a potential target in colorectal cancer using novel fluorescent GPCR ligands

Identification of V6.51L as a selectivity hotspot in stereoselective A<sub>2B</sub> adenosine receptor antagonist recognition.

Potent and Subtype-Selective Dopamine D2 Receptor Biased Partial Agonists Discovered via an Ugi-Based Approach

Enantiomeric Separation and Molecular Modelling of Bioactive 4-Aryl-3,4-dihydropyrimidin-2(1H)-one Ester Derivatives on Teicoplanin-Based Chiral Stationary Phase

Similarities and differences upon binding of naturally occurring Δ<sup>9</sup>-tetrahydrocannabinol-derivatives to cannabinoid CB<sub>1</sub> and CB<sub>2</sub> receptors.

Catalytic performance of a metal-free graphene oxide-Al2O3 composite assembled by 3D printing

Collaborators (11)

Willem Jespers

Irene Reyes-Resina

Mónica Gómez Boado

Eddy Sotelo

Jose Brea

Antón Leandro Martínez Rodríguez

Hugo Gutiérrez de Terán

Álvaro Gil

Xinsong Chen

Cosimo Altomare

Apple Tay

Make your next move.